OPTN
Price:
$0.9517
Market Cap:
$143.49M
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the co...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-10-13
Stock Exchange
NASDAQ
Ticker
OPTN
According to OptiNose, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.80. This represents a change of -26.96% compared to the average of -3.83 of the last 4 quarters.
The mean historical PE Ratio of OptiNose, Inc. over the last ten years is -1.66. The current -2.80 PE Ratio has changed 16.81% with respect to the historical average. Over the past ten years (40 quarters), OPTN's PE Ratio was at its highest in in the June 2023 quarter at 13.11. The PE Ratio was at its lowest in in the December 2016 quarter at -22.71.
Average
-1.66
Median
-2.31
Minimum
-17.93
Maximum
22.45
Discovering the peaks and valleys of OptiNose, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 95.88%
Maximum Annual PE Ratio = 22.45
Minimum Annual Increase = -225.21%
Minimum Annual PE Ratio = -17.93
Year | PE Ratio | Change |
---|---|---|
2023 | -4.07 | 95.88% |
2022 | -2.08 | 84.42% |
2021 | -1.13 | -44.50% |
2020 | -2.03 | -42.65% |
2019 | -3.54 | 53.32% |
2018 | -2.31 | -45.62% |
2017 | -4.25 | -118.94% |
2016 | 22.45 | -225.21% |
The current PE Ratio of OptiNose, Inc. (OPTN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.43
5-year avg
-2.57
10-year avg
-1.66
OptiNose, Inc.’s PE Ratio is less than Collegium Pharmaceutical, Inc. (12.07), less than Phibro Animal Health Corporation (324.20), less than ANI Pharmaceuticals, Inc. (43.28), less than Procaps Group S.A. (4.69), less than Silver Spike Investment Corp. (14.29), less than Lifecore Biomedical, Inc. (12.14), less than Kamada Ltd. (20.40), less than Shuttle Pharmaceuticals Holdings, Inc. (-0.48), less than Cumberland Pharmaceuticals Inc. (-1.76), less than Ironwood Pharmaceuticals, Inc. (77.85), less than Amphastar Pharmaceuticals, Inc. (13.33), less than Eagle Pharmaceuticals, Inc. (5.10), less than Alkermes plc (15.66), greater than Evolus, Inc. (-17.34), less than Prestige Consumer Healthcare Inc. (18.08), greater than Regencell Bioscience Holdings Limited (-18.48), less than Neurocrine Biosciences, Inc. (35.71), greater than Intra-Cellular Therapies, Inc. (-90.48), greater than Deciphera Pharmaceuticals, Inc. (-11.74), less than Dynavax Technologies Corporation (84.07),
Company | PE Ratio | Market cap |
---|---|---|
12.07 | $1.20B | |
324.20 | $788.20M | |
43.28 | $1.27B | |
4.69 | $218.91M | |
14.29 | $71.22M | |
12.14 | $147.38M | |
20.40 | $307.52M | |
-0.48 | $3.42M | |
-1.76 | $18.25M | |
77.85 | $720.42M | |
13.33 | $2.21B | |
5.10 | $55.19M | |
15.66 | $4.42B | |
-17.34 | $928.12M | |
18.08 | $3.68B | |
-18.48 | $87.06M | |
35.71 | $12.13B | |
-90.48 | $7.77B | |
-11.74 | $2.21B | |
84.07 | $1.45B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OptiNose, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OptiNose, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is OptiNose, Inc.'s PE Ratio?
How is the PE Ratio calculated for OptiNose, Inc. (OPTN)?
What is the highest PE Ratio for OptiNose, Inc. (OPTN)?
What is the 3-year average PE Ratio for OptiNose, Inc. (OPTN)?
What is the 5-year average PE Ratio for OptiNose, Inc. (OPTN)?
How does the current PE Ratio for OptiNose, Inc. (OPTN) compare to its historical average?